The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Andrew Edouard Buscaglia - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
: One thing, if you look into your sales guidance for next year, if you back out NDC, the implied organic sales is more like mid-single
digits. So I was wondering -- I know you gave a lot of color already, but I would think that in some areas like medical and even
electronics, you see a reacceleration, I think, mid- to late-year. And I just wonder how conservative you're being on that with that as
a dynamic in the forecast.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
DECEMBER 16, 2021 / 1:30PM, NDSN.OQ - Q4 2021 Nordson Corp Earnings Call
Question: Andrew Edouard Buscaglia - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
: Okay. Is there a way -- sorry, go ahead.
Question: Andrew Edouard Buscaglia - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
: Well, I was just going to say, with medical, I would think that, that's being held up by recent variant's activity again. So I would just
think that, that would only be a nice tailwind as the year progresses.
Question: Andrew Edouard Buscaglia - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
: Okay. Okay. That's helpful. Is there a way in that backlog that you can identify what percent of sales is specific to electronics and
medical?
|